Dyne Therapeutics grants new hires stock options for 278,100 shares, plus 88,400 restricted stock units
DYN•Inducement equity awards for new hires
Dyne Therapeutics granted inducement equity awards to 14 new hires under its 2024 Inducement Stock Incentive Plan.
- Non-statutory stock options cover 278,100 shares, priced at the Sept. 15 Nasdaq closing price, with a 10-year term.
- The options vest over four years, starting with 25% after one year, then quarterly installments, subject to continued service.
- Restricted stock units cover 88,400 shares, vesting in four equal annual installments over four years, subject to continued service.
